Current filters:  
United States
Haug Partners
On July 24, 2023, the United States Court of Appeals for the Federal Circuit issued a precedential opinion in United Therapeutics Corp. v. Liquidia Technologies, Inc.
Jones Day
On August 22, 2023, the Federal Circuit issued a nonprecedential decision holding that claims directed to deuterated analogs of ruxolitinib were unpatentable as obvious. Sun Pharm. Indus
Wolf, Greenfield & Sacks, P.C.
Getting a new product to market is a time-consuming and difficult task that few achieve. Yet, the husband and wife team of Greg Besner and Leslie Hsu have done just that with their Sunflow...
Winston & Strawn LLP
On September 19, 2023, Judge Albright issued a discovery dispute order ordering plaintiff Viasat Inc. (Viasat) to produce "documents and information sufficient to identify which of its products...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The USPTO recently extended the After Final Consideration Pilot (AFCP) 2.0 to September 30, 2024. AFCP 2.0 is part of the USPTO's ongoing effort toward compact prosecution...
Goodwin Procter LLP
As we previously reported, REGENXBIO Inc. and the Trustees of the University of Pennsylvania filed suit in Delaware in June 2023 against Sarepta Therapeutics, Inc., Sarepta Therapeutics Three, LLC...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
These changes to corporate ownership and funding disclosure requirements have had significant impacts on practice in Judge Connolly's court.
Marshall, Gerstein & Borun LLP
According to a recent district court decision, an artificial intelligence (AI) cannot be an "author" as that term is defined by U.S. copyright law.
Wolf, Greenfield & Sacks, P.C.
That is, patent owners will often accuse petitioners of raising "new arguments" at trial.
Volpe Koenig
This episode of IP Goes Pop!®, takes you on a journey through the iconic world of the Barbie universe and brand, exploring its deep-rooted connections with pop culture and intellectual property law.
Oblon, McClelland, Maier & Neustadt, L.L.P
Federal Circuit applied Amgen v. Sanofi, 598 U.S. 594 (2013)in deciding that claims 1-4, 19 and 20 of Baxalta's hemophilia patent, U.S. Patent 7,033,590 (‘590)...
NovoTech Patent Firm
In Volvo Penta of the Americas, LLC v. Brunswick Corp., Case No. 22-1765 (Fed. Cir. Aug. 24, 2023) (Moore, Lourie, Cunningham, JJ.), the Federal Circuit reversed the Board's obviousness rejection...
Akin Gump Strauss Hauer & Feld LLP
A Petitioner filed a request for rehearing and a request for Precedential Opinion Panel review after the Patent Trial and Appeal Board (PTAB or the "Board") rejected its petition for post-grant review.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The USPTO implemented the Patent Prosecution Highway (PPH) back in May of 2010. It's been around for a while but sometimes a forgotten tool in some technology fields.
Wolf, Greenfield & Sacks, P.C.
Technology companies and manufacturers know that they do not infringe a patent if they (or their products) do not practice a claimed invention. But did you know that there are certain circumstances...
Goodwin Procter LLP
We previously reported on patent infringement litigations between Alnylam and Moderna. Below we provide updates on two proceedings involving the mRNA vaccine producer Moderna.
Jones Day
In a precedential opinion, the Court of Appeals for the Federal Circuit vacated a final written decision in which the Patent Trial and Appeal Board ("PTAB") found that Apple...
Vorys Sater Seymour & Pease
So Your Brand Wants To Sue, What Should It Do...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
35 U.S.C. § 284 provides that, where infringement is found, "the court shall award . . . damages adequate to compensate for the infringement but in no event less than a reasonable royalty for the use made of the invention by the infringer."
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media